SCHEMBL6996400

SCHEMBL6996400

CCC(C)(O)c1ccc2c(c1)N=C(N)C(C)O2

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PIKFYVE Q9Y2I7 1/20 0.32
ESR1 P03372 1/20 0.30
ESR2 Q92731 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8119455 0.89
SCHEMBL7988326 0.83 ALDH1A1 (0.35) ESR1ESR2
SCHEMBL7708028 0.79 NOS3 (0.43)
SCHEMBL7001034 0.72 LMNA (0.33) ESR1ESR2
SCHEMBL7985549 0.71 MAPT (0.43) ESR1ESR2
SCHEMBL6991828 0.71 PARP1 (0.49)
SCHEMBL6996663 0.70 SLC6A4 (0.34)
SCHEMBL6611984 0.69 PARP1 (0.45)
SCHEMBL7985616 0.66 MAPT (0.47) ESR1ESR2
SCHEMBL5670575 0.66 ESR1 (0.35) ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015437-B1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AG (DE) 2003-12-03 EP disclosed
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed